DESCRIPTION:

Dr. Gajewski will provide an overview of foundational cancer immunology discoveries made within his lab and the program as well as background on how these discoveries inform clinical development of new therapies. Dr. Olson will review these clinical trials, the current field of melanoma therapies and an overview of emerging therapies.

 

LEARNING OBJECTIVES

1.    to learn about ongoing research in cancer immunotherapy within the melanoma program

2.    to learn about updates to the field of melanoma therapies in 2025

3.    to learn about ongoing and upcoming melanoma clinical trials based on programmatic research

Session date: 
08/04/2025 - 12:00pm to 1:00pm CDT
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please login or create an account to proceed.
Speaker Name: 
Daniel Olson, MD and Thomas Gajewski, MD, PhD